Harmony Biosciences (HRMY) Misses Q4 EPS by 29c
Tweet
Share
E-mail
Get Alerts HRMY Hot Sheet
Join SI Premium – FREE
Harmony Biosciences (NASDAQ: HRMY) reported Q4 EPS of $0.57, $0.29 worse than the analyst estimate of $0.86. Revenue for the quarter came in at $243.8 million versus the consensus estimate of $239.23 million.
For earnings history and earnings-related data on Harmony Biosciences (HRMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Movano (MOVE) Misses Q2 EPS by 195c
- Reading (RDI) Tops Q2 EPS by 4c
- Phillips 66, Marathon Merger Talks Collapsed - Semafor
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
